Search clinical trials for: machine-learning algorithm

Total 10000 results

‹
1
2
...
61
62
63
64
65
66
67
...
199
200
›

Basque Health Service

Unknown

Plasma Rich Growth Factors in Venous Ulcers

Venous Ulcers

Spain
Vaxine Pty Ltd
Australian Respiratory and Sleep Medicine Institute

Recruiting

Autologous Tumour Vaccine Trial

Solid Tumor

Australia
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection

Gonococcal Infection

United States, Thailand, Malawi
University of Wisconsin, Madison

Completed

Determining the Relationship Between Gut Microbiota and Immune Response to Influenza or COVID-19 Vaccine

Inflammatory Bowel Diseases

United States
The University of Hong Kong

Completed

Community-based Sero-epidemiological Study of COVID-19

COVID-19

Hong Kong
The University of Queensland
Coalition for Epidemic Preparedness Innovations

Completed

A FIRST IN HUMAN TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF SARS-CoV-2 UQSC2 VACCINE IN HEALTHY ADULTS.

COVID-19

Australia
National Institute of Allergy and Infectious Diseases...

Completed

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)

HIV Infections

United States
Pfizer

Completed

Immunogenicity, Safety and Tolerability of a Neisseria Meningitidis Serogroup B Bivalent Recominant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Toddlers.

Meningococcal B Disease

Australia, Poland, Finland, Czechia
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Respiratory Syncytial Virus Infections

United States
Hopital du Sacre-Coeur de Montreal
GlaxoSmithKline

Completed

Risk of Narcolepsy Associated With Administration of H1N1 Vaccine

Narcolepsy

Canada
Novartis Vaccines

Completed

Study to Evaluate Safety, Tolerability and Immunogenicity of a Bedside Mixing Combination of Two Adjuvanted Influenza Vaccines

Influenza

Switzerland
OrganOx Ltd.
North American Science Associates Ltd.

Completed

WP01 - Normothermic Liver Preservation

Liver Transplantation

United States
Bristol-Myers Squibb

Completed

Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

Atrial Fibrillation
Bristol-Myers Squibb

Completed

Replication Of An Early Evaluation Of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin In The U.S

Atrial Fibrillation
Pfizer

Completed

Study Comparing a 13-valent Pneumococcal Conjugate Vaccine With 23-valent Pneumococcal Polysaccharide Vaccine in Adults

Pneumococcal Infections

United States
Walvax Biotechnology Co., Ltd.

Completed

Immunogenicity and Safety Study of the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine in 2-71 Months Old Healthy Infants and Toddlers (the Youngest Could be 6 Weeks Old)

Diseases Caused by Streptococcus Pneumoniae Serotypes
GlaxoSmithKline

Completed

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.

Tuberculosis

Switzerland
National Institute of Allergy and Infectious Diseases...
Merck Sharp & Dohme LLC; Cooperative Clinical Trials in Pediatric Transplantation and other collaborators

Terminated

Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients

Kidney Transplant Recipients

United States
Pauline Verdijk
World Health Organization

Completed

Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy Adults

Poliomyelitis

Poland
Green Signal Biopharma Private Limited

Completed

A Study of Comparing Safety and Reactogenicity, of Lyophilized BCG Vaccine IP of Green Signal Bio Pharma Private Limited, India With BCG Vaccine of Serum Institute of India Limited in 120 Healthy Children.

Healthy

India
GlaxoSmithKline
Finnish Vaccine Research;; Dr Arto Palmu

Recruiting

A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland

Herpes Zoster

Finland
Hubei Bio-Pharmaceutical Industrial Technological...

Not yet recruiting

A Phase 2 Study of HW091077 in Participants With Refractory Chronic Cough Or Unexplained Chronic Cough (RCC/UCC).

Refractory Chronic Cough
International Vaccine Institute

Recruiting

Effectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-typhoidal Salmonella Disease (VINS)

Malaria | Malaria Vaccine | Invasive Non-Typhoidal Salmonella Disease

Democratic Republic of the Congo
Fudan University
Merck Sharp & Dohme LLC

Not yet recruiting

Evaluation of a Vaccine Chatbot on HPV Vaccine Confidence and Hesitancy

HPV Vaccine
Washington University School of Medicine

Recruiting

SGLT2 Inhibitors in Geographic Atrophy

Eye Diseases | Retinal Degeneration | Retinal Diseases | Pathological Conditions, Anatomical | Geographic Atrophy

United States
Ascletis Pharma (China) Co., Limited

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis

Plaque Psoriasis

United States
Assiut University

Not yet recruiting

Effect of COVID-19 Pandemic on Vaccination Compliance

Vaccine Refusal
Bayer

Completed

A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese Volunteers.

Sepsis Associated Disseminated Intravascular Coagulation (DIC)

Japan
Celldex Therapeutics

Completed

A Study of CDX-0159 in Patients With Eosinophilic Esophagitis (EvolvE)

Eosinophilic Esophagitis

United States, Australia, Spain, United Kingdom, Canada, Italy, Germany, Poland
Biogen

Enrolling by invitation

An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus (EMERALD)

Systemic Lupus Erythematosus (SLE)

United States, Brazil, Israel, Spain, Bulgaria, China, Belgium, Serbia, Taiwan, Japan, Mexico, Argentina, Chile, Poland, Philippines, Romania, Colombia, Hungary, Czechia, United Kingdom, Peru, Italy, Puerto Rico, Greece, France, South Korea
Valneva Austria GmbH
Coalition for Epidemic Preparedness Innovations; Fundação Butantan

Enrolling by invitation

Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil

Chikungunya Virus Infection

Brazil
Valneva Austria GmbH
Coalition for Epidemic Preparedness Innovations; Fundação Butantan

Enrolling by invitation

Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination Strategy in Brazil

Chikungunya Virus Infection

Brazil
Valneva Austria GmbH
Coalition for Epidemic Preparedness Innovations; Fundação Butantan

Active, not recruiting

Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil

Chikungunya Virus Infection

Brazil
Boehringer Ingelheim

Completed

A Study to Test How Well Different Doses of BI 1815368 Are Tolerated by Healthy Men

Healthy

Belgium
GlaxoSmithKline

Completed

Safety, Tolerability and Pharmacokinetics of GSK3923868 Inhalation Powder in Healthy Participants and Stable Asthmatics

Pulmonary Disease, Chronic Obstructive

United Kingdom
GTx

Withdrawn

Durability Extension Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Stress Urinary Incontinence

Stress Urinary Incontinence

United States
AstraZeneca

Completed

Study With CIN-107 Following Multiple Oral Ascending Doses in Healthy Subjects

Hypertension

United States
Boehringer Ingelheim

Completed

A Study to Test How Healthy Women Tolerate Different Doses of BI 1819479

Healthy

Germany
Cyclerion Therapeutics

Terminated

Study of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Type I or II Achalasia

Achalasia

United States
Novartis Pharmaceuticals

Terminated

A Safety, Tolerability and Efficacy Study in Chronic Obstructive Pulmonary Disease (COPD) Patients With QBM076.

COPD

Germany, United Kingdom, United States, Romania
Boehringer Ingelheim

Completed

Single Rising Dose Study of BI 135585 XX in Health Asian Male Volunteers.

Healthy

Korea, Republic of
Panacea Biotec Ltd

Unknown

Study Of Single Ascending Doses Of PBL 1427 In Healthy Volunteers

Diabetes Mellitus

India
Vertex Pharmaceuticals Incorporated

Completed

Study of VX-985 in Subjects With Chronic Hepatitis C

Chronic Hepatitis C

United States
GlaxoSmithKline

Completed

A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

Measles | Measles; Mumps; Rubella; Chickenpox

Taiwan, United States, Colombia, Puerto Rico, Latvia
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Completed

Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine

Streptococcus Pneumoniae Infections

China
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network; IPPOX Foundation; EuroVacc Foundation; Global Solutions...

Withdrawn

Evaluating the Safety and Immune Response to Two HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults in the United States and South Africa

HIV Infections
GlaxoSmithKline

Completed

3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age

Neisseria Meningitidis | Haemophilus Influenzae Type b

Belgium, Germany
Novartis Vaccines

Completed

Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years

Pertussis | Whooping Cough | Tetanus | Diphtheria | Lockjaw

Belgium
Medical College of Wisconsin
University of Wisconsin, Madison; Amgen

Recruiting

Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT

B-cell Acute Lymphoblastic Leukemia | B-cell Childhood Acute Lymphoblastic Leukemia | B-Cell ALL, Childhood

United States
Asuman Kucukoner

Completed

Speech in Noise Discrimination Skills in Multiple Sclerosis Patients.

Multiple Sclerosis-Relapsing-Remitting

Turkey

‹
1
2
...
61
62
63
64
65
66
67
...
199
200
›

Subscribe